The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration

Completed

Conditions studied: HIV Infections, AIDS, Opiate Dependence, Post-Traumatic Stress Disorders

In brief

The goal of this study is to develop and evaluate an innovative model of care to better serve patients who are both HIV-infected and opioid-dependent.

Key facts

Study ID

NCT00227357

Run by

Ruth M. Rothstein CORE Center

People needed

101

Starts

2005-07-01

Expected to finish

2008-12-01

Last updated by the study team

2010-06-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years or older
• Patient of the CORE Center
• HIV-infected (confirmed by HIV assay results)
• Opioid-dependent (by Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision [DSM-IV-TR] criteria)
• Fluent in English or Spanish
• Planning to stay in Chicago area for the next 12 months

You may not qualify if…

• Liver function tests (LFTs) (transaminase only) at 5 times or higher than normal
• DSM-IV-TR criteria for benzodiazepine abuse or dependence within the past 6 months
• DSM-IV-TR criteria for alcohol dependence within the past 6 months or actively suicidal
• Psychiatric impairment that impedes ability to consent
• Methadone dose exceeds level allowing for safe transition to buprenorphine
• Pregnant women or women actively trying to become pregnant
• Clinical judgement that patient is inappropriate for medical or psychiatric reasons

Where it is running

• The CORE Center — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.